Go to deals
Healthcare

Dr. Leahu Dental Clinics has raised capital through a bond private placement to accelerate its expansion plans

Dr. Leahu Dental Clinics has raised US$2.4 million through a bond private placement targeting local high-net-worth individuals and small asset managers. The bond issuance was listed on Bucharest Stock Exchange, is denominated in RON, has a three year maturity period (due in 2022) and a fixed annual coupon of 7.5%.

Dr. Leahu Dental Clinics is the leading chain of dental clinics in Romania, with ten locations across the country. Owned by its founder, the company offers a full spectrum of stomatology services, and plans to consolidate the local market both organically and through M&A.

Oaklins’ team in Romania, acted as private debt advisor and authorized consultant for the bond issuance, assisting Dr Leahu Dental Clinics’ shareholders all the way, from the start to the successful completion and listing of the financial instrument on the Bucharest Stock Exchange. During this process, the team initiated and advised on many aspects, including, among others, securing pre-commitments from cornerstone investors, deal structuring, and the bond pricing and sizing.

Talk to the deal team

Daniela Secara

Principal
Bucharest, Romania
Oaklins BT Capital

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more